Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Helix Biopharma Corp. (TSE:HBP)
:HBP
Holding TSE:HBP?
Track your performance easily
HBP Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.50 - C$1.35
Previous CloseN/A
Volume518.00
Average Volume (3M)4.71K
Market Cap
C$48.04M
Enterprise ValueC$39.97M
Total Cash (Recent Filing)$897.00K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.22
Next Earnings
Mar 12, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.20
Shares Outstanding49,021,538
10 Day Avg. Volume985
30 Day Avg. Volume4,710
Standard Deviation0.21
R-Squared0.03
Alpha-0.00870
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-14.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.83
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-9.91
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Helix BioPharma News
PremiumCompany Announcements
Helix BioPharma Secures $3 Million Through Private Placement
PremiumCompany Announcements
Helix BioPharma Appoints New CFO
PremiumCompany Announcements
Helix BioPharma Alters Share Terms Amid Financing Plans
PremiumCompany Announcements
Helix BioPharma Expands Portfolio with Key Acquisition
PremiumCompany Announcements
Helix BioPharma Secures U.S. Patent for Cancer Therapy
PremiumCompany Announcements
Helix BioPharma to Acquire Laevoroc’s Oncology AssetsPremiumCompany Announcements
Helix BioPharma Unveils Promising Cancer TreatmentPremiumCompany Announcements
Helix BioPharma Highlights L-DOS47 at World ADCOptions Prices
Currently, No data available
---
Ownership Overview
40.02%
Insiders
― Other Institutional Investors
59.98% Public Companies and
Individual Investors
HBP FAQ
What was Helix Biopharma Corp.’s price range in the past 12 months?
Helix Biopharma Corp. lowest stock price was C$0.50 and its highest was C$1.35 in the past 12 months.
What is Helix Biopharma Corp.’s market cap?
Helix Biopharma Corp.’s market cap is C$48.04M.
When is Helix Biopharma Corp.’s upcoming earnings report date?
Helix Biopharma Corp.’s upcoming earnings report date is Mar 12, 2025 which is in 52 days.
How were Helix Biopharma Corp.’s earnings last quarter?
Helix Biopharma Corp. released its earnings results on Dec 16, 2024. The company reported -C$0.027 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.027.
Is Helix Biopharma Corp. overvalued?
According to Wall Street analysts Helix Biopharma Corp.’s price is currently Overvalued.
Does Helix Biopharma Corp. pay dividends?
Helix Biopharma Corp. does not currently pay dividends.
What is Helix Biopharma Corp.’s EPS estimate?
Helix Biopharma Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Helix Biopharma Corp. have?
Helix Biopharma Corp. has 49,021,538 shares outstanding.
What happened to Helix Biopharma Corp.’s price movement after its last earnings report?
Helix Biopharma Corp. reported an EPS of -C$0.027 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Helix Biopharma Corp.?
Currently, no hedge funds are holding shares in TSE:HBP
---
Company Description
Helix Biopharma Corp.
Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidates are Tumor Defence Breaker L-DOS47, and, V-DOS47 among others.
---
Technical Analysis
---